Marino Stram & Associates’s Dynavax Technologies DVAX Stock Holding History

Marino Stram & Associates’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-494	Closed	-$4K	–	208
2019 Q1	$4K	Hold	494	–	–	﹤0.01%	410
2018 Q4	$5K	Hold	494	–	–	﹤0.01%	335
2018 Q3	$6K	Hold	494	–	–	﹤0.01%	340
2018 Q2	$8K	Hold	494	–	–	0.01%	315
2018 Q1	$10K	Hold	494	–	–	0.01%	309
2017 Q4	$9K	Buy	+494	New	+$9.92K	0.01%	315

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Marino Stram & Associates's DVAX Position: Q2 2019 in Review

Marino Stram & Associates sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 494 shares — an estimated $4K sold.

Marino Stram & Associates first reported a position in DVAX in Q4 2017 and held it in 6 quarters. The position peaked at $10K in Q1 2018. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

Marino Stram & Associates reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
Marino Stram & Associates sold 494 Dynavax Technologies shares in Q2 2019, an estimated $4K.
Marino Stram & Associates first reported a position in Dynavax Technologies in Q4 2017 and held it in 6 quarters.
Marino Stram & Associates's Dynavax Technologies position peaked at $10K in Q1 2018.
127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.